GSK Taiwan, Hospital Sign R&D MOU Aimed At Specific Discoveries
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline Taiwan and Taiwan's Chang Gung Memorial Hospital have agreed to create a joint research-and-development center in the country aimed at discovering drugs for clinical diagnoses.